Biblio

Author Title [ Type

] Year

Filters: Author is Fritsche, Ellen [Clear All Filters]

Journal Article

Nimtz L, Hartmann J, Tigges J, Masjosthusmann S, Schmuck M, Keßel E, Theiss S, Köhrer K, Petzsch P, Adjaye J, et al. Characterization and application of electrically active neuronal networks established from human induced pluripotent stem cell-derived neural progenitor cells for neurotoxicity evaluation. Stem Cell Res. 2020;45:101761.

Fritsche E, Barenys M, Klose J, Masjosthusmann S, Nimtz L, Schmuck M, Wuttke S, Tigges J. Corrigendum to "Current Availability of Stem Cell-Based In Vitro Methods for Developmental Neurotoxicity (DNT) Testing". Toxicol Sci. 2018.

Uhlmann C, Kuhn L-M, Tigges J, Fritsche E, Kahlert UDietrich. Efficient Modulation of TP53 Expression in Human Induced Pluripotent Stem Cells. Curr Protoc Stem Cell Biol. 2020;52(1):e102.

Blum J, Masjosthusmann S, Bartmann K, Bendt F, Dolde X, Dönmez A, Förster N, Holzer A-K, Hübenthal U, Keßel HEike, et al. Establishment of a human cell-based in vitro battery to assess developmental neurotoxicity hazard of chemicals. Chemosphere. 2022:137035.

Li L, Tang LYin, Liang B, Wang R, Sun Q, San Lau CBik, Leung PChung, Fritsche E, Liebsch M, Seiler A, et al. Evaluation of in vitro embryotoxicity tests for Chinese herbal medicines. Reprod Toxicol. 2019.

Barenys M, Fritsche E. A Historical Perspective on the Use of Stem/Progenitor Cell-Based In Vitro Methods for Neurodevelopmental Toxicity Testing. Toxicol Sci. 2018;165(1):10-13.

Kapr J, Petersilie L, Distler T, Lauria I, Bendt F, Sauter CM, Boccaccini AR, Rose CR, Fritsche E. Human Induced Pluripotent Stem Cell-Derived Neural Progenitor Cells Produce Distinct Neural 3D In Vitro Models Depending on Alginate/Gellan Gum/Laminin Hydrogel Blend Properties. Adv Healthc Mater. 2021:e2100131.

Bartmann K, Bendt F, Dönmez A, Haag D, H Keßel E, Masjosthusmann S, Noel C, Wu J, Zhou P, Fritsche E. A human iPSC-based in vitro neural network formation assay to investigate neurodevelopmental toxicity of pesticides. ALTEX. 2023.

Uhlmann C, Nickel A-C, Picard D, Rossi A, Li G, Hildebrandt B, Brockerhoff G, Bendt F, Hübenthal U, Hewera M, et al. Progenitor cells derived from gene-engineered human induced pluripotent stem cells as synthetic cancer cell alternatives for in vitro pharmacology. Biotechnol J. 2022:e2100693.